Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Linmei Gao, Yuming Ding, Yanru Zhao, Wentong Lin
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local citing links have been materialized yet.
Contemporary contrast media dosing during percutaneous coronary intervention in patients with pre-existing renal impairment
10.25270/jic/24.00313 · 2025
Acute kidney injury in patients continued on renin-angiotensin system blockers during hospitalization
10.1016/j.amjms.2016.09.012 · 2017
Structural renal changes in obesity and diabetes
10.1016/j.semnephrol.2012.12.003 · 2013
Endothelial function, CRP and oxidative stress in chronic kidney disease
10.1093/joneph/18.6.721 · 2005
Renal safety and survival among acutely ill hospitalized patients treated by blockers of the renin-angiotensin axis or loop diuretics: a single-center retrospective analysis
10.1080/0886022x.2023.2282707 · 2023
Contrast-induced nephropathy: from pathophysiology to preventive strategies
10.1016/j.cjca.2015.05.013 · 2016
Adding insult to injury: the spectrum of tubulointerstitial responses in acute kidney injury
10.1172/jci188358 · 2025
Neutrophil gelatinase-associated lipocalin (NGAL) for the prediction of acute kidney injury in chronic kidney disease patients treated with primary percutaneous coronary intervention
10.1016/j.ijcha.2020.100695 · 2021
Pathophysiology of acute kidney injury
10.1002/j.2040-4603.2012.tb00431.x · 2012
Progression after AKI: understanding maladaptive repair processes to predict and identify therapeutic treatments
10.1681/asn.2015030309 · 2016
Protein-bound uremic toxins from gut microbiota and inflammatory markers in chronic kidney disease
10.1053/j.jrn.2016.07.005 · 2016
Proenkephalin for the early detection of acute kidney injury in hospitalized patients with chronic kidney disease
10.1111/eci.12999 · 2018
Circulating proenkephalin, acute kidney injury, and its improvement in patients with severe sepsis or shock
10.1373/clinchem.2018.288068 · 2018
Mitochondrial dysfunction and metabolic reprogramming in acute kidney injury: mechanisms, therapeutic advances, and clinical challenges
10.3389/fphys.2025.1623500 · 2025
Tubular disease: mistargeted protein disrupts mitochondrial metabolism in inherited Fanconi syndrome
10.1038/nrneph.2014.6 · 2014
Chronic kidney disease and superimposed acute kidney injury: greater impact of acute insults on outcomes
10.1155/ijne/1353892 · 2026
High plasma C-terminal FGF-23 levels predict poor outcomes in patients with chronic kidney disease superimposed with acute kidney injury
10.1177/2040622320964161 · 2020
Mitochondrial signaling, the mechanisms of AKI-to-CKD transition and potential treatment targets
10.3390/ijms25031518 · 2024
Acute kidney injury and chronic kidney disease: an integrated clinical syndrome
10.1038/ki.2012.208 · 2012
Acute kidney injury and chronic kidney disease as interconnected syndromes
10.1056/nejmra1214243 · 2014
Increased plasma fibroblast growth factor 23 and In-hospital acute kidney injury after cardiac surgery
10.1097/aln.0000000000005605 · 2025
Sepsis-associated acute kidney disease incidence, trajectory, and outcomes
10.1016/j.xkme.2024.100959 · 2025
Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis
10.1038/ki.2011.379 · 2012
Urinary KIM-1 correlates with the subclinical sequelae of tubular damage persisting after the apparent functional recovery from intrinsic acute kidney injury
10.3390/biomedicines10051106 · 2022
Proenkephalin expression and enkephalin release are widely observed in non-neuronal tissues
10.1016/j.peptides.2007.11.004 · 2008
Plasma neutrophil gelatinase-associated lipocalin in acute kidney injury superimposed on chronic kidney disease after cardiac surgery: a multicenter prospective study
10.1186/cc13104 · 2013
Pathophysiological implications of fibroblast growth factor-23 and klotho and their potential role as clinical biomarkers
10.1373/clinchem.2013.206649 · 2014
Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review
10.1007/s00228-012-1259-9 · 2012
Prediction of mortality and need for renal replacement therapy in patients of acute kidney injury using fibroblast growth factor 23
10.4103/1319-2442.270259 · 2019
Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD
10.1038/nrneph.2015.3 · 2015
Inflammation in kidney repair: mechanism and therapeutic potential
10.1016/j.pharmthera.2022.108240 · 2022
Drug-induced acute kidney injury: a cohort study on incidence, identification of pathophysiological mechanisms, and prognostic factors
10.3389/fmed.2024.1459170 · 2024
The role of interleukin-4 in acute kidney injury and chronic kidney disease: a literature review
10.1186/s12882-026-04879-0 · 2026
Chronic kidney disease and aging: dissecting the p53/p21 pathway as a therapeutic target
10.1007/s10522-024-10173-z · 2024
Mechanisms of NLRP3 priming in inflammaging and age related diseases
10.1016/j.cytogfr.2020.08.003 · 2020
Mitochondrial dysfunction in the pathophysiology of renal diseases
10.1152/ajprenal.00189.2023 · 2024
New insights into acute-on-chronic kidney disease in nephrology patients: the CKD-REIN study
10.1093/ndt/gfab249 · 2022
Kidney injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury
10.1046/j.1523-1755.2002.00433.x · 2002
Urinary biomarkers in the early diagnosis of acute kidney injury
10.1038/sj.ki.5002715 · 2008
AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms
10.1016/j.kint.2017.06.030 · 2017
Acute kidney injury, acute kidney disease and chronic kidney disease: challenges and research perspectives
10.1093/ndt/gfaf090 · doi-reference
Acute and acute-on-chronic kidney injury of patients with decompensated heart failure: impact on outcomes
10.1186/1471-2369-13-51 · doi-reference
Acute kidney injury in critically ill patients with sepsis: clinical characteristics and outcomes
10.1080/08941939.2018.1453891 · doi-reference
Transition from acute kidney injury to chronic kidney disease: mechanisms, models, and biomarkers
10.1152/ajprenal.00184.2024 · doi-reference
Risk factors and prognosis of acute kidney injury after cardiac surgery in patients with chronic kidney disease
10.1159/000526120 · doi-reference
From acute tubular injury to tubular repair and chronic kidney diseases - KIM-1 as a promising biomarker for predicting renal tubular pathology
10.1016/j.crphys.2025.100152 · doi-reference
Kidney injury molecule-1 (KIM-1) mediates renal epithelial cell repair via ERK MAPK signaling pathway
10.1007/s11010-016-2700-7 · doi-reference
Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease
10.1681/asn.2014050457 · doi-reference
Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study
10.1007/s00134-023-07169-7 · doi-reference
Sepsis-associated acute kidney injury: consensus report of the 28th acute disease quality initiative workgroup
10.1038/s41581-023-00683-3 · doi-reference
Repeated administration of cisplatin transforms kidney fibroblasts through G2/M arrest and cellular senescence
10.3390/cells11213472 · doi-reference
Ceftriaxone calcium crystals induce acute kidney injury by NLRP3-Mediated inflammation and oxidative stress injury
10.1155/2020/6428498 · doi-reference
Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential
10.1007/s00018-017-2639-1 · doi-reference
KIM-1-mediated phagocytosis reduces acute injury to the kidney
10.1172/jci75417 · doi-reference
Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury
10.1038/nm.2144 · doi-reference
Targeted degradation of kidney injury molecule 1 ameliorates acute kidney injury
10.1016/j.ijbiomac.2026.150099 · doi-reference
Proenkephalin predicts kidney function and major adverse kidney events in CKD
10.1093/ndt/gfaf214 · doi-reference
Sepsis-associated acute kidney injury in patients with chronic kidney disease: patient characteristics, prevalence, timing, trajectory, treatment and associated outcomes
10.1111/nep.14392 · doi-reference
Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications
10.1016/s0002-9343(99)00113-8 · doi-reference
Failed tubule recovery, AKI-CKD transition, and kidney disease progression
10.1681/asn.2015010006 · doi-reference
Role of renal hypoxia in the progression from acute kidney injury to chronic kidney disease
10.1016/j.semnephrol.2019.10.006 · doi-reference
Calcium phosphate-induced injury in kidney tubular cells-supersaturated solution vs preformed crystals
10.1002/jbt.70145 · doi-reference
Mitochondrial quality control in kidney injury and repair
10.1038/s41581-020-00369-0 · doi-reference
Immune dysfunction and risk of infection in chronic kidney disease
10.1053/j.ackd.2019.01.004 · doi-reference
Thrombospondin1 in tissue repair and fibrosis: tgf-β-dependent and independent mechanisms
10.1016/j.matbio.2012.01.006 · doi-reference
Risk factors for community-acquired acute kidney injury in patients with and without chronic kidney injury and impact of its initial management on prognosis: a prospective observational study
10.1186/s12882-017-0792-2 · doi-reference
Pre-existing renal failure worsens the outcome after intestinal ischaemia and reperfusion in rats
10.1093/ndt/gfq281 · doi-reference
Septic acute kidney injury in critically ill patients - a single-center study on its incidence, clinical characteristics, and outcome predictors
10.3109/0886022x.2016.1157749 · doi-reference
The inhibition of ZC3H13 attenuates G2/M arrest and apoptosis by alleviating NABP1 m6A modification in cisplatin-induced acute kidney injury
10.1007/s00018-025-05596-x · doi-reference
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease
10.1681/asn.2013020126 · doi-reference
Heart failure and kidney dysfunction: epidemiology, mechanisms and management
10.1038/nrneph.2016.113 · doi-reference
Long-term prognosis after acute kidney injury (AKI): what is the role of baseline kidney function and recovery? A systematic review
10.1136/bmjopen-2014-006497 · doi-reference
Regulated cell death pathways in kidney disease
10.1038/s41581-023-00694-0 · doi-reference
NAD(+) homeostasis in renal health and disease
10.1038/s41581-019-0216-6 · doi-reference
Sepsis associated acute kidney injury
10.1136/bmj.k4891 · doi-reference
Severe renal mass reduction impairs recovery and promotes fibrosis after AKI
10.1681/asn.2013040359 · doi-reference
Microvascular rarefaction and hypertension in the impaired recovery and progression of kidney disease following AKI in preexisting CKD states
10.1152/ajprenal.00419.2018 · doi-reference
Drug-induced acute kidney injury
10.2215/cjn.11290821 · doi-reference
Pharmacology behind common drug nephrotoxicities
10.2215/cjn.00150118 · doi-reference
Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment
10.1016/j.kint.2019.05.026 · doi-reference